NewsRamp Science, Exploration and Discovery Podcast

The Thomas Jefferson National Accelerator Facility plans to reduce its workforce by 7 percent through voluntary resignations while offering severance payments. Meanwhile, a new therapy utilizing mitochondria from infant placenta shows promise in slowing down aging and treating incurable diseases, with companies like Clene Inc. exploring mitochondrial health for medical advancements.

Creative Biolabs offers cutting-edge cell therapy platforms for cancer immunotherapy, focusing on CAR-T and TIL therapies. Meanwhile, a study on transboundary basins worldwide reveals low sustainability scores and highlights the importance of addressing clean water, economic growth, and health collectively to improve sustainability.

ESGold Corp. reveals promising results from a survey at the Montauban mine site in Quebec, indicating potential for metals discovery. Columbia University scientists have developed a groundbreaking cancer treatment using bacteria to deliver anti-cancer viruses directly into tumors. Additionally, Sethera Therapeutics introduces an enzymatic platform creating durable thioether 'staples' for designing...

Research published in Stroke indicates that vaginal estrogen tablets are safe for postmenopausal women post-stroke, offering a viable option for managing menopausal symptoms without increasing stroke risk. Additionally, Creative Biogene's antibody purification platform provides high-yield, high-purity antibodies for various biotechnology applications, enhancing research capabilities.

Mainly Mozart has chosen Dr. Erica Ollmann Saphire, President and CEO of La Jolla Institute for Immunology, as the recipient of the 2025 San Diego Genius Award. Her groundbreaking research on viruses like Ebola and SARS-CoV-2 has been instrumental in global vaccine design efforts. In another collaboration, BioMed X and Novo Nordisk are working together to enhance oral peptide drug delivery, aiming...

Ascentage Pharma initiates Phase III trial for Lisaftoclax in higher-risk MDS patients, University of Rochester develops material for solar thermoelectric generators, and Fathom Nickel Inc. completes summer field exploration program at Gochager Lake Project despite wildfire disruption.

Soligenix Inc. receives FDA Orphan Drug Designation for dusquetide in Behçet’s Disease, showcasing positive Phase 2a results. On the other hand, Creative Biolabs offers specialized antibody QC services and a scholarship program for students in biology and related fields, emphasizing innovation in antibody development.

Torr Metals Inc. announced high-grade copper discoveries at the Bertha Zone in British Columbia, showcasing significant mineralization and potential porphyry targets. Meanwhile, Soligenix Inc. is advancing a heat-stable ricin vaccine, RiVax(R), with promising efficacy and plans for pivotal animal studies to combat the deadly biothreat of ricin toxin.

A study in Pakistan highlighted the seismic vulnerability of non-engineered structures in Dir City, emphasizing the need for stricter regulations and retrofitting. In satellite navigation, a new method integrating inter-satellite link data with onboard observations significantly improves orbit determination precision. Additionally, a LEGO-like hydrogel system developed in Beijing enables reversibl...

Maryland faces federal funding cuts in its science and engineering research sector, while states like Massachusetts propose support for research institutions. Lahontan Gold Corp. is advancing its Santa Fe Mine project in Nevada, BioCorRx Inc. reports substantial revenue growth driven by LUCEMYRA® sales, and Intensity Therapeutics revolutionizes cancer treatment with innovative approaches. Addition...

Creative Biolabs is a leading biotechnology company offering tailored liposomal drug delivery services to accelerate gene therapy research. With a focus on nucleic acid and prodrug loading, they provide customizable formulations for enhanced stability, release kinetics, and target specificity, all while maintaining regulatory compliance and global availability for research purposes.

Annovis Bio Inc. provided updates on their Phase 3 trial for early Alzheimer’s disease, with 76 secured U.S. sites and enrollment progressing as planned. The company presented at AAIC 2025, expanded global IP coverage, and reported cash and equivalents of $17.1 million as of June 30, 2025. Quarterly R&D expenses were $5.2 million, G&A expenses decreased to $1.1 million, and net loss per share narr...

NRx Pharmaceuticals Inc. is making waves on Wall Street with its groundbreaking therapies for suicidal bipolar depression. With promising drugs like NRX-100 and NRX-101, along with strategic moves like Fast Track Designation and removing toxic preservatives from ketamine products, NRx is poised for success in the biopharmaceutical industry. With a focus on offering life-saving therapies through HO...

Quantum BioPharma Ltd. plans a private placement for general working capital, while Ucore Rare Metals Inc. receives a $18.4 million award from the U.S. Department of Defense to fast-track its Louisiana Strategic Metals Complex, aiming to establish itself as a reliable North American source of heavy rare earth elements.

AAA Biotech has expanded its portfolio with more rProteins, offering researchers in life sciences access to high-quality recombinant proteins for various applications such as protein-protein interactions and drug discovery. Through rigorous quality control and customization options, AAA Biotech aims to support and advance biomedical research efforts. Visit their official website for more informati...

Trusted clinical research partnerships drive medical advancements in treating pediatric gliomas and suicidal ideation, while mining companies like ESGold Corp. focus on revenue generation and mine site revitalization. Financial firms like Alliance Global Partners maintain optimistic outlooks for companies such as Soligenix Inc., while Quantum BioPharma Ltd. progresses with an oral formulation for...

Chinese researchers have developed a groundbreaking treatment for lung cancer by transplanting mitochondria into tumors, enhancing chemotherapy effectiveness. Quantum BioPharma Ltd. collaborates with Massachusetts General Hospital on a PET tracer to detect MS-related changes and evaluates a neuroprotective drug for myelin sheath protection.

Stonegate Capital Partners provides an update on BlackSky Technology, Inc., highlighting revenue growth, new contracts, satellite launches, and a successful convertible note offering. The American Heart Association raises concerns about the health impact of ultraprocessed foods and emphasizes the importance of reducing consumption. Researchers introduce a new nanoelectromechanical system accelerom...

Join the Girl Scouts of Southeast Florida at STEMapalooza 2025 for a hands-on STEM learning experience. Soligenix Inc. is highlighted for its rare disease innovation with the HyBryte(TM) platform. ARTBIO, Inc. announces new board appointments for advancing alpha radioligand programs. LaFleur Minerals Inc. launches a drilling campaign at the Swanson Gold Project, while Aston Bay Holdings Ltd. repor...

Energy Fuels Inc. reported record uranium grades at its Pinyon Plain mine and progress in rare earth operations, while GeoVax Labs, Inc. responded to HHS terminating mRNA vaccine contracts by advocating for MVA-based multi-antigen vaccines like GEO-CM04S1, highlighting deficiencies in mRNA vaccines and emphasizing the need for evidence-backed alternatives.

Lantern Pharma's subsidiary Starlight Therapeutics has received FDA clearance to begin a Phase Ib/2a clinical trial for glioblastoma multiforme treatment. Eloro Resources Ltd. reports positive assay results from drilling program in Bolivia. Additionally, a genetic discovery holds promise for enhancing cancer immunotherapy, particularly in ovarian clear cell carcinoma patients.

ABVC BioPharma secures a $2.5 million investment from international investors, signaling confidence in their therapeutic innovations. Meanwhile, a study from Denmark reveals that excessive screen time among youth is associated with increased heart health risks, emphasizing the importance of addressing screen habits to protect long-term health.

This podcast episode highlights recent advancements in various industries, including iRocket's partnership with SpaceBelt KSA for satellite launches, EnPlusOne Biosciences' enzymatic RNA synthesis technology, ProtoSpace Mfg's sponsorship of a planetary rover challenge, Soligenix Inc.'s efforts in developing treatments for rare diseases, the impact of chronic inflammation on depression treatments f...

Intensity Therapeutics, Inc. secures $6.6 million for clinical trials, Trilogy Metals Inc. positions itself as a key player in the mining industry, a study explores EV battery reuse vs. recycling, and NRx Pharmaceuticals, Inc. petitions FDA for a ban on Benzethonium Chloride in ketamine products, focusing on developing safer therapeutics.

Neutra Life Sciences, a subsidiary of Neutra Corp, is expanding rapidly through joint venture partnerships with Podiatry Epic Foot & Ankle Centers, Radiation Oncology Aspire Hospital Cancer Centers, and Dermatology Radiant Dermatology & Aesthetics Clinic. This diversification into various specialties aims to meet the growing demand for high-quality clinical research solutions, accelerating the dev...